Outcomes Superior for HM3 LVAD Regardless of Preimplant Strategy
WEDNESDAY, Jan. 15, 2020 -- For patients with advanced heart failure, the HeartMate 3 (HM3) left ventricular assist device (LVAD) is superior to the HeartMate II (HMII), regardless of whether the device is a bridge to transplant (BTT) or a...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Cardiology | Heart | Heart Failure | Heart Transplant | Pharmaceuticals | Transplant Surgery | Transplants